Form 8-K - Current report:
SEC Accession No. 0001493152-25-002575
Filing Date
2025-01-16
Accepted
2025-01-16 17:09:53
Documents
13
Period of Report
2025-01-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37849
  Complete submission text file 0001493152-25-002575.txt   206632

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE sigy-20250111.xsd EX-101.SCH 3042
3 XBRL LABEL FILE sigy-20250111_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE sigy-20250111_pre.xml EX-101.PRE 22377
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3371
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

EIN.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55575 | Film No.: 25536348
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)